A range of unique Rh-based bidentate NHC complexes that are formed in a base-free tandem isomerization/ cyclometalation process were synthesized (1−4) from a range of imidazolium salts with an N-alkenyl tether. Cyclometalation occurred with complex 1, leading to an unprecedented complex, which is the first and only example in the literature of a nonaromatic C(sp 2 )−H activation leading to a C(sp 3 )−Rh cyclometalated product with a concomitant intramolecular/ isomerization process. Dealkylation of the N-alkenyl substituent occurred to form byproducts that showed metal N-coordination (1b and 2b). These byproducts, 1b and 2b, were further reacted with the anion exchange reagent NH 4 PF 6 to form the dimeric complexes 1bd and 2bd. All of the complexes were applied as precatalysts in the hydrosilylation of internal alkynes with excellent performance (conversions of 66−100%) after only 1 h at 80 °C without the use of an additive. Anticancer studies showed that complexes presented half-maximum inhibitory concentrations ranging from 3.71 to 25.85 μM. Depending on the cell line, complex 4 was the most cytotoxic complex, especially in the BT-20 triple-negative breast carcinoma, MCF-12A nontumorigenic mammary gland cell, MDA-MB-231 triple-negative breast carcinoma, and MCF-7/TAMR-1 tamoxifen-resistant subtype of the MCF-7 estrogen-and progesterone-positive luminal breast carcinoma cell lines.